07/16/2013
https://congress.gov...
"CREATES addresses a tactic the company that makes Revlimid, Celgene, uses to deny generic companies access to samples of Revlimid."
"Some on the other side of the aisle... feel that these high drug prices represent a failure of markets, a failure of capitalism."
"The cost of prescription drugs is way too high."
"Followed the law, developed a product that people want, a product that is going to take us away from more harmful, traditional cigarettes, a product that can actually help you phase off of using nicot..."